Interleukin 12 a key immunoregulatory cytokine in infection applications

International Journal of Molecular Sciences

Volumn 11, Issue 3, 2010, Pages 789-806

  Hamza, Therwa ^a,b   Barnett, John B ^c   Li, Bingyun ^a,b,d,e  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d WVNano Initiative   (United States)

^e West Virginia University   (United States)

Author keywords

Cell signaling; Cell mediated immunity; Infection; Interferon ; Interleukin 12

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INFLUENZA VACCINE; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P35; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 35; RECOMBINANT GLYCOPROTEIN GP 120;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; BONE INFECTION; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNOREGULATION; INFECTION PREVENTION; INFECTION RESISTANCE; INFLUENZA; INFLUENZA VIRUS A; INNATE IMMUNITY; LUNG METASTASIS; LYMPHOCYTE DIFFERENTIATION; MOLECULAR WEIGHT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OSTEOMYELITIS; OVARY CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STAPHYLOCOCCUS AUREUS; TH1 CELL; TUBERCULOSIS;

CELL SIGNALING; CELL-MEDIATED IMMUNITY; INFECTION; INTERFERON-Γ; INTERLEUKIN 12;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-12; MOLECULAR SEQUENCE DATA; VIRUS DISEASES;

BACTERIA (MICROORGANISMS);

EID: 77950909696     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11030789     Document Type: Review

References (83)

1. Mosmann, T.R.; Coffman, R.L. TH1 and TH2 cells: different patterns of cytokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989, 7, 145-173.
2. Chehimi, J.; Trinchieri, G. Interleukin-12: A bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 1994, 14, 149-161.
3. Aggarwal, S.; Ghilardi, N.; Xie, M.H.; de Sauvage, F.J.; Gurney, A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003, 278, 1910-1914.
4. Beadling, C.; Slifka, M.K. Regulation of innate and adaptive immune responses by the related cytokines IL-12, IL-23, and IL-27. Arch. Immunol. Ther. Exp. 2006, 54, 15-24.
5. Sinigaglia, F.; D'Ambrosio, D.; Panina-Bordignon, P.; Rogge, L. Regulation of the IL-12/IL-12R axis: A critical step in T-helper cell differentiation and effector function. Immunol. Rev. 1999, 170, 65-72.
6. Merberg, D.M.; Wolf, S.F.; Clark, S.C. title typecontributorSequence similarity between NKSF and the IL-6/G-CSF family/title. Immunol. Today 1992, 13, 77-78.
7. Gearing, D.P.; Cosman, D. Homology of the p40 subunit of natural killer cell stimulatory factor (NKSF) with the extracellular domain of the interleukin-6 receptor. Cell 1991, 66, 9-10.
8. D'Andrea, A.; Rengaraju, M.; Valiante, N.M.; Chehimi, J.; Kubin, M.; Aste, M.; Chan, S.H.; Kobayashi, M.; Young, D.; Nickbarg, E.; Chizzonite, R.; Wolf, S.F.; Trinchieri, G. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 1992, 176, 1387-1398.
9. Gately, M.K.; Carvajal, D.M.; Connaughton, S.E.; Gillessen, S.; Warrier, R.R.; Kolinsky, K.D.; Wilkinson, V.L.; Dwyer, C.M.; Higgins, G.F. Jr.; Podlaski, F.J.; Faherty, D.A.; Familletti, P.C.; Stern, A.S.; Presky, D.H. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann. NY Acad. Sci. 1996, 795, 1-12.
10. Ling, P.; Gately, M.K.; Gubler, U. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 1995, 154, 116-127.
11. Khader, S.A.; Partida-Sanchez, S.; Bell, G.; Jelley-Gibbs, D.M.; Swain, S.; Pearl, J.E.; Ghilardi, N.; Desauvage, F.J.; Lund, F.E; Cooper, A.M. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 2006, 203, 1805-1815.
12. Presky, D.H.; Yang, H.; Minetti, L.J.; Chua, A.O.; Nabavi, N.; Wu, C.Y.; Gately, M.K.; Gubler, U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 1996, 93, 14002-14007.
13. Collison, L.W.; Vignali, D.A. Interleukin-35: Odd one out or part of the family? Immunol. Rev. 2008, 226, 248-262.
14. Trinchieri, G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3, 133-146.
15. Brombacher, F.; Kastelein, R.A.; Alber, G. Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 2003, 24, 207-212.
16. Parham, C.; Chirica, M.; Timans, J.; Vaisberg, E.; Travis, M.; Cheung, J.; Pflanz, S.; Zhang, R.; Singh, K.P.; Vega, F.; To, W.; Wagner, J.; O'Farrell, A.M.; McClanahan, T.; Zurawski, S.; Hannum, C.; Gorman, D.; Rennick, D.M.; Kastelein, R.A.; de Waal Malefyt, R.; Moore, K.W. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002, 168, 5699-5708.
17. Oppmann, B.; Lesley, R.; Blom, B.; Timans, J.C.; Xu, Y.; Hunte, B.; Vega, F.; Yu, N.; Wang, J.; Singh, K.; Zonin, F.; Vaisberg, E.; Churakova, T.; Liu, M.; Gorman, D.; Wagner, J.; Zurawski, S.; Liu, Y.; Abrams, J.S.; Moore, K.W.; Rennick, D.; de Waal-Malefyt, R.; Hannum, C.; Bazan, J.F.; Kastelein, R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000, 13, 715-725.
18. + T cells. J. Immunol. 2004, 173, 3871-3877.
19. + T cells. Immunity 2002, 16, 779-790.
20. Collison, L.W.; Workman, C.J.; Kuo, T.T.; Boyd, K.; Wang, Y.; Vignali, K.M.; Cross, R.; Sehy, D.; Blumberg, R.S.; Vignali, D.A. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450, 566-569.
21. Niedbala, W.; Wei, X.Q.; Cai, B.; Hueber, A.J.; Leung, B.P.; McInnes, I.B.; Liew, F.Y. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur. J. Immunol. 2007, 37, 3021-3029.
22. Bacon, C.M.; Petricoin, E.F., III; Ortaldo, J.R. Rees R.C.; Larner A.C.; Johnston J.A.; O'Shea J.J. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 1995, 927, 307-311.
23. Mullen, A.C.; High, F.A.; Hutchins, A.S.; Lee, H.W.; Villarino, A.V.; Livingston, D.M.; Kung, A.L.; Cereb, N.; Yao, T.P.; Yang, S.Y.; Reiner, S.L. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 2001, 292, 1907-1910.
24. Lighvani, A.A.; Frucht, D.M.; Jankovic, D.; Yamane, H.; Aliberti, J.; Hissong, B.D.; Nguyen, B.V.; Gadina, M.; Sher, A.; Paul, W.E.; O'Shea, J.J. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 2001, 98, 15137-15142.
25. Usui, T.; Preiss, J.C.; Kanno, Y.; Yao, Z.J.; Bream, J.H.; O'Shea, J.J.; Strober, W. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J. Exp. Med. 2006, 203, 755-766.
26. Szabo, S.J.; Dighe, A.S.; Gubler, U.; Murphy, K.M. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 1997, 185, 817-824.
27. Boehm, U.; Klamp, T.; Groot, M; Howard, J.C. Cellular responses to interferon-γ. Annu Rev. Immunol. 1997, 15, 749-795.
28. Goriely, S.; Neurath, M.F.; Goldman, M. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 2008, 8, 81-86.
29. Gautier, G.; Humbert, M.; Deauvieau, F.; Scuiller, M.; Hiscott, J.; Bates, E.E.; Trinchieri, G.; Caux, C.; Garrone, P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005, 201, 1435-1446.
30. Re, F.; Strominger, J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 2001, 276, 37692-37699.
31. + dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 2001, 194, 1021-1032.
32. Carmody, R.J.; Ruan, Q.; Liou, H.C.; Chen, Y.H. Essential roles of c-Rel in TLR-induced IL-23 p19 gene expression in dendritic cells. J. Immunol. 2007, 178, 186-191.
33. Wirtz, S.; Becker, C.; Fantini, M.C.; Nieuwenhuis, E.E.; Tubbe, I.; Galle, P.R.; Schild, H.J.; Birkenbach, M.; Blumberg, R.S.; Neurath, M.F. EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-κB activation. J. Immunol. 2005, 174, 2814-2824.
34. Watford, W.T.; Moriguchi, M.; Morinobu, A.; O'Shea, J.J. The biology of IL-12: Coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 2003, 14, 361-368.
35. Airoldi, I.; Guglielmino, R.; Carra, G.; Corcione, A.; Gerosa, F.; Taborelli, G.; Trinchieri, G.; Pistoia, V. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes. Haematologica 2002, 87, 434-442.
36. Aragane, Y.; Riemann, H.; Bhardwaj, R.S.; Schwarz, A.; Sawada, Y.; Yamada, H.; Luger, T.A.; Kubin, M.; Trinchieri, G.; Schwarz, T. IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J. Immunol. 1994, 153, 5366-5372.
37. Bost, K.L.; Ramp, W.K.; Nicholson, N.C.; Bento, J.L.; Marriott, I.; Hudson, M.C. Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production. J. Infect. Dis. 1999, 180, 1912-1920.
38. Aste-Amezaga, M.; Ma, X.; Sartori, A.; Trinchieri, G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J. Immunol. 1998, 160, 5936-5944.
39. Segal, B.M.; Dwyer, B.K.; Shevach, E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 1998, 187, 537-546.
40. Bonecchi, R.; Bianchi, G.; Bordignon, P.P.; D'Ambrosio, D.; Lang, R.; Borsatti, A.; Sozzani, S.; Allavena, P.; Gray, P.A.; Mantovani, A.; Sinigaglia, F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998, 187, 129-134.
41. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 1995, 182, 1759-1767.
42. Austrup, F.; Vestweber, D.; Borges, E.; Löhning, M.; Bräuer, R.; Herz, U.; Renz, H.; Hallmann, R.; Scheffold, A.; Radbruch, A.; Hamann, A. P-and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflammed tissues. Nature 1997, 385, 81-83.
43. Loetscher, M.; Loetscher, P.; Brass, N.; Meese, E.; Moser, B. Lymphocyte-specific chemokine receptor CXCR3: Regulation, chemokine binding and gene localization. Eur. J. Immunol. 1998, 28, 3696-3705.
44. Gazzinelli, R.T.; Wysocka, M.; Hayashi, S.; Denkers, E.Y.; Hieny, S.; Caspar, P.; Trinchieri, G.; Sher, A. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol. 1994, 1536, 2533-2543.
45. Gately, M.K.; Chizzonite, R.; Presky, D.H. Measurement of human and mouse interleukin-12. Curr. Protoc. Immunol. 2001, 6.16.1-6.16.15.
46. Wilkinson, V.L.; Warrier, R.R.; Truitt, T.P.; Nunes, P.; Gately, M.K.; Presky, D.H. Characterization of anti-mouse IL-12 monoclonal antibodies and measurement of mouse IL-12 by ELISA. J. Immunol. Methods. 1996, 189, 15-24.
47. Shiratori, I.; Matsumoto, M.; Tsuji, S.; Nomura, M.; Toyoshima, K.; Seya, T. Molecular cloning and functional characterization of guinea pig IL-12. Int. Immunol. 2001, 13, 1129-1139.
48. Shiratori, I.; Suzuki, Y.; Oshiumi, H.; Begum, N.A.; Ebihara, T.; Matsumoto, M.; Hazekim, K.; Kodama, K.; Kashiwazaki, Y.; Seya, T. Recombinant interleukin-12 and interleukin-18 antitumor therapy in a guinea-pig hepatoma cell implant model. Cancer Sci. 2007, 98, 1936-1942.
49. Novelli, F.; Casanova, J.L. The role of IL-12, IL-23 and IFN-gamma in immunity to viruses. Cytokine Growth Factor Rev. 2004, 15, 367-377.
50. Hendricks, R.L.; Janowicz, M.; Tumpey, T.M. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 1992, 148, 2522-2529.
51. Matsuo, R.; Kobayashi, M.; Herndon, D.N.; Pollard, R.B.; Suzuki, F. Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J. Leukoc. Biol. 1996, 59, 623-630.
52. Harandi, A.M.; Svennerholm, B.; Holmgren, J.; Eriksson, K. Interleukin-12 (IL-12) and IL-18 are important in innate defense against genital herpes simplex virus type 2 infection in mice but are not required for the development of acquired gamma interferon-mediated protective immunity. J. Virol. 2001, 75, 6705-6709.
53. + CTL responses in vitro. J. Clin. Invest. 1996, 98, 715-722.
54. Gross, P.A.; Hermogenes, A.W.; Sacks, H.S.; Lau, J.; Levandowski, R.A. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann. Int. Med. 1995, 123, 518-527.
55. de Boer, T.; van Dissel, J.T.; Kuijpers, T.W.; Rimmelzwaan, G.F.; Kroon, F.P.; Ottenhoff, T.H. Influenza virus vaccination induces interleukin-12/23 receptor beta 1 (IL-12/23R beta 1)-independent production of gamma interferon (IFN-gamma) and humoral immunity in patients with genetic deficiencies in IL-12/23R beta 1 or IFN-gamma receptor I. Clin. Vaccine Immunol. 2008, 15, 1171-1175.
56. Maggi, E.; Mazzetti, M.; Ravina, A.; Annunziato, F.; de Carli, M.; Piccinni, M.P.; Manetti, R.; Carbonari, M.; Pesce, A.M.; del Prete, G. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 1994, 265, 244-248.
57. Balter, M. Elusive HIV-suppressor factors found. Science 1995, 270, 1560-1561.
58. Hudson, M.C.; Ramp, W.K.; Nicholson, N.C.; Williams, A.S.; Nousiainen, M.T. Internalization of Staphylococcus aureus by cultured osteoblasts. Microb. Pathog. 1995, 6, 409-419.
59. Almeida, R.A.; Matthews, K.R.; Cifrian, E.; Guidry, A.J.; Oliver, S.P. Staphylococcus aureus invasion of bovine mammary epithelial cells. J. Dairy Sci. 1996, 79, 1021-1026.
60. Marriott, I. Osteoblast responses to bacterial pathogens: A previously unappreciated role for bone-forming cells in host defense and disease progression. Immunol. Res. 2004, 30, 291-308.
61. Torti, D.C.; Feldman, S.R. Interleukin-12, interleukin-23, and psoriasis: Current prospects. J. Am. Acad. Dermato. 2007, 57, 1059-1068.
62. Hultgren, O.H.; Stenson, M.; Tarkowski, A. Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res. 2001, 3, 41-47.
63. Sutterwala, F.S.; Noel, G.J.; Clynes, R.; Mosser, D.M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 1997, 185, 1977-1985.
64. Marth, T.; Neurath, M.; Cuccherini, B.A.; Strober, W. Defects of monocyte interleukin 12 production and humoral immunity in Whipple's disease. Gastroenterology 1997, 113, 442-448.
65. O'Sullivan, S.T.; Lederer, J.A.; Horgan, A.F.; Chin, D.H.; Mannick, J.A.; Rodrick, M. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann. Surg. 1995, 222, 482-490.
66. Napolitano, L.M.; Napolitano, L.M.; Koruda, M.J.; Meyer, A.A.; Baker, C.C. The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 1996, 5, 202-207.
67. Huynh, T.; Lemasters, J.J.; Bracey, L.W.; Baker, C.C. Proinflammatory Kupffer cell alterations after femur fracture trauma and sepsis in rats. Shock 2000, 14, 555-560.
68. Spolarics, Z.; Siddiqi, M.; Siegel, J.H.; Garcia, Z.C.; Stein, D.S.; Denny, T.; Deitch, E.A. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit. Care Med. 2003, 31, 1722-1729.
69. Li, B.; Jiang, B.; Boyce, B.M.; Lindsey, B.A. Multilayer polypeptide nanoscale coatings incorporating IL-12 for the prevention of biomedical device-associated infections. Biomaterials 2009, 30, 2552-2558.
70. Li, B.; Jiang, B.; Dietz, M.J.; Smith, E.S.; Clovis, N.B.; Rao, K.M.K. Evaluation of local MCP-1 and IL-12 nanocoatings for infection prevention in open fractures. J. Orthop. Res. 2010, 28, 48-54.
71. Murray, H.W. Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense. In vitro, in animal models, and in humans. Diagn. Microbiol. Infect. Dis. 1990, 13, 411-421.
72. Worth, L.L.; Jia, S.F.; Zhou, Z.; Chen, L.; Kleinerman, E.S. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Clin. Cancer Res. 2000, 6, 3713-3718.
73. Lenzi, R.; Edwards, R.; June, C.; Seiden, M.V.; Garcia, M.E.; Rosenblum, M.; Freedman, R.S. Phase II study of intraperitoneal recombinant interleukin-12 (rhIL-12) in patients with peritoneal carcinomatosis (residual disease < 1 cm) associated with ovarian cancer or primary peritoneal carcinoma. J. Transl. Med. 2007, 5, 66.
74. Egilmez, N.K.; Jong, Y.S.; Sabel, M.S.; Jacob, J.S.; Mathiowitz, E.; Bankert, R.B. In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: Iinduction of tumor regression and potent antitumor immunity. Cancer Res. 2000, 60, 3832-3837.
75. Bajetta, E.; Del Vecchio, M.; Mortarini, R.; Nadeau, R.; Rakhit, A.; Rimassa, L.; Fowst, C.; Borri, A.; Anichini, A.; Parmiani, G. Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res. 1998, 4, 75-85.
76. Daud, A.I.; DeConti, R.C.; Andrews, S.; Urbas, P.; Riker, A.I.; Sondak, V.K.; Munster, P.N.; Sullivan, D.M.; Ugen, K.E.; Messina, J.L.; Heller, R. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J. Clin. Oncol. 2008, 26, 5896-5903.
77. O'Suilleabhain, C.; O'Sullivan, S.T.; Kelly, J.L.; Lederer, J.; Mannick, J.A.; Rodrick, M.L. Interleukin-12 treatment restores normal resistance to bacterial challenge after burn injury. Surgery 1996, 120, 290-296.
78. Orme, I.M.; Miller, E.S.; Roberts, A.D.; Furney, S.K.; Griffin, J.P.; Dobos, K.M.; Chi, D.; Rivoire, B.; Brennan, P.J. T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens. J. Immunol. 1992, 148, 189-196.
79. Flynn, J.L.; Goldstein, M.M.; Triebold, K.J.; Sypek, J.; Wolf, S.; Bloom, B.R. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 1995, 155, 2515-2524.
80. Cooper, A.M.; Khader, S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 2008, 226, 191-204.
81. Jiang, B.; Li, B. Tunable drug incorporation and release from polypeptide multilayer nanofilms. Int. J. Nanomed. 2009, 4, 37-53.
82. Zhao, Q.; Li, B. pH-controlled drug loading and release from biodegradable microcapsules. Nanomed.: Nanotechnol. Biol. Med. 2008, 4, 302-310.
83. Haynie, D.T.; Palath, N.; Liu, Y.; Li, B.; Pargaonkar, N. Biomimetic nanotechnology: Inherent reversible stabilization of polypeptide microcapsules. Langmuir 2005, 21, 1136-1138.